withdrawal from glp 1 Following discontinuation of GLP‐1 receptor agonists (GLP‐1RAs), the GLP‑1 therapies can deliver impressive

Try the GLP-1 Support Stack today

The review concludes that future research must establish evidence-based screening protocols, determine optimal glucose nadir cut-off values for diagnosis, and evaluate long-term outcomes for offspring exposed to maternal hypoglycemia.

Aims/hypothesis Unimolecular peptides targeting the receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) have been shown to improve glycaemic management in both mice and humans

China had 947 GLP-1 clinical trials in 2025

The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trial Phytother Res

We report an unusual case of diabetic ketoalkalosis, a mixed acid-base disorder, in a 57-year-old female patient with insulin-dependent T2DM following a switch to Mounjaro (tirzepatide)